Yatharth Hospital & Trauma Care Services Limited Share Price & Analysis
Price Chart
Fundamentals
Strengths
- Low debt relative to equity (D/E 0.2x)
Concerns
- Trading near 52-week high (₹1,025)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,899 | ₹4.6L Cr | 36.1 | 5.46 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹9,100 | ₹2.4L Cr | 81.1 | 14.42 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,857 | ₹1.8L Cr | 82.8 | 19.58 | 27.4 | 15.2 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,650 | ₹1.2L Cr | 59.1 | 13.13 | 21.2 | 17.4 | 0.88 |
| CIPLA Cipla Limited | ₹1,385 | ₹1.1L Cr | 31.3 | 3.25 | 11.6 | 15.5 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,120 | ₹1.1L Cr | 23 | 4.16 | 21.2 | 21.1 | 0.38 |
| LAURUSLABS Laurus Labs Limited | ₹1,840 | ₹99K Cr | 90.9 | 18.74 | 18.3 | 17.8 | 0.46 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
YATHARTH · as of Mar 2026
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 66.44% | 66.54% | 66.54% | 66.54% | 61.44% | 61.64% |
| FII | 2.59% | 3.99% | 4.90% | 6.28% | 9.78% | 4.45% |
| DII | 8.81% | 9.30% | 9.40% | 6.97% | 11.50% | 13.56% |
| Public | 22.15% | 20.15% | 19.16% | 20.20% | 17.27% | 20.35% |
Corporate Events
Interim Dividend - Re 0.50 Per Share
To consider and approve the Unaudited Financial Results (Standalone & Consolidated) of the Company for the period ended Jun 30, 2026, dividend and other business matters.
Annual General Meeting
Latest News
All newsAster, Advent eye Yatharth Hospitals in healthcare consolidation
*Aster, Advent eye Yatharth Hospitals in healthcare consolidation* as sector consolidation gains momentum. Both private players are reportedly in advanced talks to acquire stakes in Yatharth, a leading hospital chain in North India. The move signals growing investor confidence in healthcare infrastructure. Deal values could exceed **₹500 crore**, pending final terms. 📊 *STOCKS:* | 🏢 *SECTOR:* Healthcare | #MEDIUMIMPACT #Healthcare
Yatharth Hospital announces investor presentation event
*Yatharth Hospital announces investor presentation event*. Yatharth Hospital & Trauma Care Services Limited has informed the NSE about an upcoming investor presentation. The event aims to provide updates on business performance and strategic initiatives. No financial figures or major announcements were disclosed. 📊 *STOCKS:* $YATHARTH | 🏢 *SECTOR:* Healthcare | #LOWIMPACT #InvestorEvent
Yatharth Hospital grants ESOPs under 2024 scheme
*Yatharth Hospital grants ESOPs under 2024 scheme.* The company has issued employee stock options as part of its ESOP-2024 plan. This move aims to incentivize key personnel and align employee interests with long-term growth. While not impacting immediate financials, it signals internal confidence in future performance. 📊 *STOCKS:* $YATHARTH | 🏢 *SECTOR:* Healthcare | #LOWIMPACT #ESOP
Yatharth Hospitals added to MSCI India Small Cap Index
*Yatharth Hospitals added to MSCI India Small Cap Index.* This inclusion is expected to boost investor visibility and potentially drive passive fund inflows. SEBI analysts have set a target price of **₹850**, indicating strong upside potential. Index rebalancing typically enhances trading liquidity for small-cap stocks. 📊 *STOCKS:* YATHARTH | 🏢 *SECTOR:* CapitalMarkets | #MEDIUMIMPACT #indexinclusion
Financials
Quarterly Results
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹342 Cr 6.9% | ₹320 Cr 14.7% | ₹279 Cr 8.1% | ₹258 Cr 11.2% | ₹232 Cr 5.9% | ₹219 Cr 0.5% | ₹218 Cr 2.8% | ₹212 Cr |
| Op. Profit | ₹80 Cr 8.1% | ₹74 Cr 13.8% | ₹65 Cr 1.6% | ₹64 Cr 12.3% | ₹57 Cr 3.6% | ₹55 Cr 0.0% | ₹55 Cr 1.9% | ₹54 Cr |
| OPM | 23.0% 0.0% | 23.0% 0.0% | 23.0% 8.0% | 25.0% 0.0% | 25.0% 0.0% | 25.0% 0.0% | 25.0% 0.0% | 25.0% |
| Net Profit | ₹45 Cr 4.7% | ₹43 Cr 4.9% | ₹41 Cr 2.4% | ₹42 Cr 7.7% | ₹39 Cr 30.0% | ₹30 Cr 3.2% | ₹31 Cr 3.3% | ₹30 Cr |
| EPS (₹) | 4.93 4.7% | 4.71 10.0% | 4.28 1.8% | 4.36 8.5% | 4.02 27.2% | 3.16 12.5% | 3.61 2.0% | 3.54 |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹1.2K Cr 40.3% | ₹860 Cr 35.4% | ₹635 Cr 32.8% | ₹478 Cr 27.5% | ₹375 Cr 74.4% | ₹215 Cr 58.1% | ₹136 Cr 49.5% | ₹91 Cr 16.7% | ₹78 Cr 9.9% | ₹71 Cr |
| Expenses | ₹915 Cr 44.1% | ₹635 Cr 40.2% | ₹453 Cr 32.1% | ₹343 Cr 30.4% | ₹263 Cr 78.9% | ₹147 Cr 50.0% | ₹98 Cr 38.0% | ₹71 Cr 18.3% | ₹60 Cr 13.2% | ₹53 Cr |
| Op. Profit | ₹292 Cr 29.8% | ₹225 Cr 23.6% | ₹182 Cr 34.8% | ₹135 Cr 20.5% | ₹112 Cr 64.7% | ₹68 Cr 78.9% | ₹38 Cr 90.0% | ₹20 Cr 11.1% | ₹18 Cr 0.0% | ₹18 Cr |
| OPM | 24.0% 7.7% | 26.0% 10.3% | 29.0% 3.6% | 28.0% 6.7% | 30.0% 6.3% | 32.0% 14.3% | 28.0% 27.3% | 22.0% 8.3% | 24.0% 4.0% | 25.0% |
| Other Income | ₹26 Cr 62.5% | ₹16 Cr 0.0% | ₹16 Cr 433.3% | ₹3 Cr 50.0% | ₹2 Cr 100.0% | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Interest | ₹7 Cr 41.7% | ₹12 Cr 9.1% | ₹11 Cr 52.2% | ₹23 Cr 0.0% | ₹23 Cr 15.0% | ₹20 Cr 0.0% | ₹20 Cr 185.7% | ₹7 Cr 40.0% | ₹5 Cr 16.7% | ₹6 Cr |
| Depreciation | ₹88 Cr 54.4% | ₹57 Cr 96.6% | ₹29 Cr 3.6% | ₹28 Cr 0.0% | ₹28 Cr 33.3% | ₹21 Cr 0.0% | ₹21 Cr 162.5% | ₹8 Cr 33.3% | ₹6 Cr 14.3% | ₹7 Cr |
| PBT | ₹224 Cr 30.2% | ₹172 Cr 9.6% | ₹157 Cr 78.4% | ₹88 Cr 39.7% | ₹63 Cr 125.0% | ₹28 Cr 1500.0% | ₹-2 Cr 140.0% | ₹5 Cr 37.5% | ₹8 Cr 60.0% | ₹5 Cr |
| Tax % | 24.0% 0.0% | 24.0% 11.1% | 27.0% 8.0% | 25.0% 16.7% | 30.0% 0.0% | 30.0% 266.7% | -18.0% 185.7% | 21.0% 8.7% | 23.0% 43.9% | 41.0% |
| Net Profit | ₹170 Cr 29.8% | ₹131 Cr 14.9% | ₹114 Cr 72.7% | ₹66 Cr 50.0% | ₹44 Cr 120.0% | ₹20 Cr 1100.0% | ₹-2 Cr 150.0% | ₹4 Cr 33.3% | ₹6 Cr 100.0% | ₹3 Cr |
| EPS (₹) | 18.2 34.3% | 13.55 1.7% | 13.33 32.8% | 10.04 49.0% | 6.74 39.2% | 11.09 1503.8% | -0.79 132.5% | 2.43 35.2% | 3.75 69.7% | 2.21 |
| Div Payout | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
Liabilities | ||||||||||
| Equity Capital | ₹96 Cr 0.0% | ₹96 Cr 11.6% | ₹86 Cr 30.3% | ₹66 Cr 0.0% | ₹66 Cr 312.5% | ₹16 Cr 0.0% | ₹16 Cr 0.0% | ₹16 Cr 0.0% | ₹16 Cr 14.3% | ₹14 Cr |
| Reserves | ₹1.7K Cr 11.6% | ₹1.5K Cr 91.5% | ₹788 Cr 573.5% | ₹117 Cr 129.4% | ₹51 Cr 8.9% | ₹56 Cr 47.4% | ₹38 Cr 2.6% | ₹39 Cr 4.9% | ₹41 Cr 41.4% | ₹29 Cr |
| Borrowings | ₹264 Cr 2100.0% | ₹12 Cr 85.9% | ₹85 Cr 68.2% | ₹267 Cr 1.1% | ₹264 Cr 36.8% | ₹193 Cr 0.5% | ₹194 Cr 10.9% | ₹175 Cr 40.0% | ₹125 Cr 47.1% | ₹85 Cr |
| Other Liabilities | ₹237 Cr 107.9% | ₹114 Cr 90.0% | ₹60 Cr 66.7% | ₹36 Cr 20.0% | ₹45 Cr 4.7% | ₹43 Cr 10.3% | ₹39 Cr 50.0% | ₹26 Cr 136.4% | ₹11 Cr 10.0% | ₹10 Cr |
| Total Liabilities | ₹2.3K Cr 31.8% | ₹1.7K Cr 69.9% | ₹1.0K Cr 109.7% | ₹486 Cr 14.1% | ₹426 Cr 37.9% | ₹309 Cr 7.7% | ₹287 Cr 11.7% | ₹257 Cr 33.2% | ₹193 Cr 39.9% | ₹138 Cr |
Assets | ||||||||||
| Fixed Assets | ₹1.3K Cr 106.6% | ₹605 Cr 36.9% | ₹442 Cr 47.8% | ₹299 Cr 1.3% | ₹303 Cr 20.7% | ₹251 Cr 32.8% | ₹189 Cr 15.2% | ₹164 Cr 209.4% | ₹53 Cr 1.9% | ₹54 Cr |
| CWIP | ₹102 Cr 54.1% | ₹222 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr 100.0% | ₹62 Cr 4.6% | ₹65 Cr 40.9% | ₹110 Cr 71.9% | ₹64 Cr |
| Investments | ₹2 Cr 97.3% | ₹74 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Other Assets | ₹928 Cr 11.9% | ₹829 Cr 43.7% | ₹577 Cr 208.6% | ₹187 Cr 52.0% | ₹123 Cr 112.1% | ₹58 Cr 61.1% | ₹36 Cr 33.3% | ₹27 Cr 10.0% | ₹30 Cr 50.0% | ₹20 Cr |
| Total Assets | ₹2.3K Cr 31.8% | ₹1.7K Cr 69.9% | ₹1.0K Cr 109.7% | ₹486 Cr 14.1% | ₹426 Cr 37.9% | ₹309 Cr 7.7% | ₹287 Cr 11.7% | ₹257 Cr 33.2% | ₹193 Cr 39.9% | ₹138 Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating CF | ₹205 Cr 36.7% | ₹150 Cr 5100.0% | ₹-3 Cr 104.7% | ₹64 Cr 6.7% | ₹60 Cr 36.4% | ₹44 Cr 12.8% | ₹39 Cr 129.4% | ₹17 Cr 0.0% | ₹17 Cr 32.0% | ₹25 Cr |
| Investing CF | ₹-598 Cr 42.4% | ₹-420 Cr 85.8% | ₹-226 Cr 1030.0% | ₹-20 Cr 61.5% | ₹-52 Cr 147.6% | ₹-21 Cr 51.2% | ₹-43 Cr 44.9% | ₹-78 Cr 52.9% | ₹-51 Cr 2.0% | ₹-50 Cr |
| Financing CF | ₹254 Cr 51.2% | ₹520 Cr 71.1% | ₹304 Cr 1788.9% | ₹-18 Cr 1700.0% | ₹-1 Cr 94.7% | ₹-19 Cr 480.0% | ₹5 Cr 89.4% | ₹47 Cr 9.3% | ₹43 Cr 65.4% | ₹26 Cr |
| Net Cash Flow | ₹-140 Cr 156.2% | ₹249 Cr 232.0% | ₹75 Cr 188.5% | ₹26 Cr 271.4% | ₹7 Cr 133.3% | ₹3 Cr 200.0% | ₹1 Cr 107.7% | ₹-13 Cr 244.4% | ₹9 Cr 800.0% | ₹1 Cr |
| Free Cash Flow | ₹-112 Cr 30.4% | ₹-161 Cr 67.7% | ₹-96 Cr 318.2% | ₹44 Cr 109.5% | ₹21 Cr 12.5% | ₹24 Cr 700.0% | ₹-4 Cr 93.3% | ₹-60 Cr 475.0% | ₹16 Cr 33.3% | ₹24 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 113d 11.7% | 128d 2.3% | 131d 59.8% | 82d 1.2% | 83d 33.9% | 62d 37.8% | 45d 6.3% | 48d 9.1% | 44d 24.1% | 58d |
| Inventory Days | 32d | — | — | — | — | — | 72d 18.2% | 88d 109.5% | 42d 10.6% | 47d |
| Days Payable | 171d | — | — | — | — | — | 347d 29.2% | 490d 362.3% | 106d 16.5% | 127d |
| Cash Conv. Cycle | -26d 120.3% | 128d 2.3% | 131d 59.8% | 82d 1.2% | 83d 33.9% | 62d 127.1% | -229d 35.3% | -354d 1670.0% | -20d 9.1% | -22d |
| Working Capital Days | 80d 26.6% | 109d 7.6% | 118d 306.9% | 29d | 0d 100.0% | -18d 79.8% | -89d 18.7% | -75d 358.6% | 29d 34.1% | 44d |
| ROCE | 12.0% 14.3% | 14.0% 41.7% | 24.0% 11.1% | 27.0% 3.8% | 26.0% 44.4% | 18.0% 157.1% | 7.0% 16.7% | 6.0% 25.0% | 8.0% | — |
Source: Screener.in · Lower days = better efficiency